Interim analyses with delayed observations in clinical trials
β Scribed by Sung C. Choi; Young Jack Lee
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 95 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
β¦ Synopsis
The interim analyses based on group sequential procedures are not convenient if the response time relative to the patient accrual rate is long. Since in most trials patients are accrued and randomized continuously, the response data from those already randomized will continue to accumulate when a trial terminates at an interim test. One should analyse all observations received after the trial terminates along with the data that led to the decision to terminate the trial. Although the most likely case is that the combined results are signi"cant, it could happen that the combined results are not signi"cant. We examined the likelihood of such an event. Our study indicated that the O'Brien}Fleming type of group sequential tests with conservative boundaries in the early stages protects from such an unsettling event.
π SIMILAR VOLUMES
Several prenatal diagnoses on fetuses at risk for MPS IIIA disease have been performed in our laboratory by measuring sulphamidase activity in amniocytes or in chorionic villi using the radioactive assay (Di Natale et al., 1993), and more recently the fluorimetric assay (Karpova et al., 1996). In bo
## Abstract Traditional drug development consists of a sequence of independent trials organized in different phases. Full development typically involves (i) a learning phase II trial and (ii) one or two confirmatory phase III trial(s). For example, in the phase II trials several doses of the new co